000 01390 a2200373 4500
005 20250517172511.0
264 0 _c20190318
008 201903s 0 0 eng d
022 _a2045-2322
024 7 _a10.1038/s41598-017-08468-y
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aAhn, Eunyong
245 0 0 _aAnalysis of population-specific pharmacogenomic variants using next-generation sequencing data.
_h[electronic resource]
260 _bScientific reports
_c09 2017
300 _a8416 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650 0 4 _aAlgorithms
650 0 4 _aComputer Simulation
650 0 4 _aDatabases, Genetic
650 0 4 _aDiabetes Mellitus, Type 2
_xgenetics
650 0 4 _aGene Frequency
650 0 4 _aGenetic Predisposition to Disease
_xgenetics
650 0 4 _aGenetics, Population
_xmethods
650 0 4 _aGenotype
650 0 4 _aHigh-Throughput Nucleotide Sequencing
_xmethods
650 0 4 _aHumans
650 0 4 _aModels, Genetic
650 0 4 _aPharmacogenetics
_xmethods
650 0 4 _aPharmacogenomic Variants
_xgenetics
650 0 4 _aPolymorphism, Single Nucleotide
700 1 _aPark, Taesung
773 0 _tScientific reports
_gvol. 7
_gno. 1
_gp. 8416
856 4 0 _uhttps://doi.org/10.1038/s41598-017-08468-y
_zAvailable from publisher's website
999 _c27527341
_d27527341